Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as MAOB inhibitors

Details for Australian Patent Application No. 2006224774 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Lohri, Bruno; Hildbrand, Stefan; Wostl, Wolfgang

Agent Spruson & Ferguson

Pub. Number AU-B-2006224774

PCT Pub. Number WO2006/097270

Priority 05102030.3 15.03.05 EP

Filing date 14 March 2006

Wipo publication date 21 September 2006

Acceptance publication date 18 August 2011

International Classifications

C07D 207/26 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/402 (2006.01) - 1-aryl-substituted, e.g. piretanide

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/097270 Priority application(s): WO2006/097270

18 August 2011 Application Accepted

  Published as AU-B-2006224774

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006224777-Compounds having immunomodulator activity

2006224771-Vitamin mixtures